JP2022541638A5 - - Google Patents

Info

Publication number
JP2022541638A5
JP2022541638A5 JP2022504580A JP2022504580A JP2022541638A5 JP 2022541638 A5 JP2022541638 A5 JP 2022541638A5 JP 2022504580 A JP2022504580 A JP 2022504580A JP 2022504580 A JP2022504580 A JP 2022504580A JP 2022541638 A5 JP2022541638 A5 JP 2022541638A5
Authority
JP
Japan
Prior art keywords
compound
carboxamide
acetyl
pyridine
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022504580A
Other languages
English (en)
Japanese (ja)
Other versions
JP7682850B2 (ja
JP2022541638A (ja
Filing date
Publication date
Priority claimed from GBGB1910608.7A external-priority patent/GB201910608D0/en
Application filed filed Critical
Publication of JP2022541638A publication Critical patent/JP2022541638A/ja
Publication of JP2022541638A5 publication Critical patent/JP2022541638A5/ja
Application granted granted Critical
Publication of JP7682850B2 publication Critical patent/JP7682850B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022504580A 2019-07-24 2020-07-24 カルシウム活性化クロライドチャネルモジュレーターとしてのピリジン誘導体 Active JP7682850B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1910608.7A GB201910608D0 (en) 2019-07-24 2019-07-24 Compounds
GB1910608.7 2019-07-24
PCT/GB2020/051785 WO2021014172A1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as calcium-activated chloride channel modulators

Publications (3)

Publication Number Publication Date
JP2022541638A JP2022541638A (ja) 2022-09-26
JP2022541638A5 true JP2022541638A5 (enExample) 2023-07-25
JP7682850B2 JP7682850B2 (ja) 2025-05-26

Family

ID=67839705

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022504580A Active JP7682850B2 (ja) 2019-07-24 2020-07-24 カルシウム活性化クロライドチャネルモジュレーターとしてのピリジン誘導体

Country Status (6)

Country Link
US (1) US12545658B2 (enExample)
EP (1) EP4003977B1 (enExample)
JP (1) JP7682850B2 (enExample)
CN (1) CN114929683B (enExample)
GB (1) GB201910608D0 (enExample)
WO (1) WO2021014172A1 (enExample)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2291749A1 (fr) * 1974-11-20 1976-06-18 Delalande Sa Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique
EA002113B1 (ru) * 1996-09-04 2001-12-24 Пфайзер Инк. Производные индазола и их использование в качестве ингибиторов фосфодиэстеразы (фдэ) типа iv и продуцирования фактора некроза опухоли (фно)
HK1052011A1 (zh) 2000-09-15 2003-08-29 Anormed Inc. 趋化因子受体结合杂环化合物
US7642277B2 (en) * 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
UY32138A (es) * 2008-09-25 2010-04-30 Boehringer Ingelheim Int Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables
BR112014030940B1 (pt) * 2012-06-11 2022-09-06 UCB Biopharma SRL Benzimidazóis que modulam tnf-alfa e composição farmacêutica compreendendo os mesmos
US9458124B2 (en) 2013-02-06 2016-10-04 Wayne State University Substituted pyran derivatives
ES2735924T3 (es) * 2015-04-17 2019-12-20 Dow Agrosciences Llc Moléculas que tienen utilidad plaguicida e intermediarios, composiciones y procesos, relacionados con ellas
PL3442947T3 (pl) 2016-04-15 2023-10-02 Epizyme, Inc. Związki arylowe lub heteroarylowe podstawione aminą jako inhibitory ehmt1 i ehmt2
GB201610854D0 (en) * 2016-06-21 2016-08-03 Entpr Therapeutics Ltd Compounds
GB201619694D0 (en) * 2016-11-22 2017-01-04 Entpr Therapeutics Ltd Compounds
AU2018211529A1 (en) 2017-01-27 2019-08-29 Genfit N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxa zin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases
WO2018195127A1 (en) 2017-04-17 2018-10-25 The Regents Of The University Of California Substituted 2-acylamino-cycloakylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel tmem16a
GB201801355D0 (en) * 2018-01-26 2018-03-14 Enterprise Therapeutics Ltd Compounds

Similar Documents

Publication Publication Date Title
US11993581B2 (en) Pyridazine compounds for inhibiting Nav1.8
RU2500673C2 (ru) Гетероциклические ингибиторы мек и способы их применения
JP2021512143A5 (enExample)
RU2402517C2 (ru) Пиразолы в качестве ингибиторов 11-бета-hsd-1
JP2021534124A5 (enExample)
CA3105657A1 (en) Pyridine carboxamide compounds for inhibiting nav1.8
CA3093851A1 (en) Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same
BRPI0412219A (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, método para regular a transdução de sinal método para tratamento ou prevenção de uma doença
JP2014530900A5 (enExample)
JP2007523155A5 (enExample)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
RU2009148673A (ru) Производные пиразинона и их применение для лечения легочных заболеваний
AU2005260821A1 (en) Fused benzamide compound and vanilloid receptor 1 (VR1) activity inhibitor
JP2008509187A5 (enExample)
JP2013510883A5 (enExample)
JP4915715B2 (ja) フェニルピリダジン誘導体及びこれを含有する医薬
AU2006212761A1 (en) Combination therapy
CA2446326A1 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
JP2020533352A5 (enExample)
RU2018136888A (ru) Нафтиридины в качестве антагонистов интегрина
WO2001025190A1 (en) Novel diarylamide derivatives and use thereof as medicines
WO1999055324A1 (en) Ccr-3 receptor antagonists
JP2017505293A5 (enExample)
JP2023544716A5 (enExample)
JP2024161441A (ja) 呼吸器疾患の処理のための新規な化合物